The Good Shroom Co.: Update on Sales Activities and AGM


Ryan Allway

January 24th, 2022

Psychedelics


MONTREALJan. 24, 2022 /CNW/ – The Good Shroom Co. Inc. (the “Company” or “TGSC“) (TSXV: MUSH) is pleased to provide some recent highlights and reminds shareholders that the annual general meeting of shareholders will be held January 25, 2022, at 10:30 am (EST) and will be accessible via Webcast. Shareholders wishing to attend can register, prior to the meeting, at https://us06web.zoom.us/meeting/register/tJwkd-2tpz0iHdf2NsSfnl84IztaKAPdGUHi. Given the current government guidelines in place, participation will be solely by Webcast.

 

 

The Good Shroom Co Inc. Logo (CNW Group/The Good Shroom Co Inc.)
The Good Shroom Co Inc. Logo (CNW Group/The Good Shroom Co Inc.)

“During this past year, and following the reverse take over transaction in April 2021, we have been refining our product offering, expanding our sales channels and strengthening our sales force for the Teonan Beverage line. We anticipate seeing positive results this current year. As well, our cannabis division is showing early signs of success as sales of the Company’s new hash brands to the SQDC (Quebec’s authorized retailer), which began December 24, 2021, have already generated $297,000 in sales over a 4-week period. Online reviews have shown our hash product, Nordique Royale’s Afghan Gold, is very well received and we believe that the quality of our products will help us gain a significant market share in the coming year.” Stated Eric Ronsse, the Chief Executive Officer of the Company.

 

 

Some key milestones for the Velada and Nordique Royale hash products:

  • In June 2021, the Company obtained the required licenses and authorization to commence the sales of its cannabis products.
  • In October 2021, the Company entered into an agreement with the Ontario Cannabis Store (“OCS”) for the purchase of Velada cannabis teas, with delivery to start in early 2022. Based on present sales of similar products, the OCS has placed a replenishment order to ensure it receives an adequate supply of Velada products.
  • In November 2021 the Company entered into an agreement with the Quebec Government to sell its Nordique Royale and Velada cannabis products. Sales of its hash brand began on December 24Quebec and have already reached $297,000. Weedcrawler.ca which tracks real time cannabis product sales has ranked Nordique Royale’s Afghan Gold hash #9 in all hash sales within only two weeks of launching, and it is now at #6. Reddit online reviews of the product also confirm that customers enjoy Nordique Royale products and are becoming loyal to the brand.

 

Some key milestones for the Teonan products:

  • The mushroom based functional beverage line under the Teonan brand, is now available in seven flavours. It can still be purchased directly through the Company’s online stores, but in addition, it is now available in the United States (US) following an agreement with an established major distributor, Kehe Distributors LLC (“Kehe”), (www.kehe.com). Kehe operates 16 distribution centers across the United States and fulfils orders from a variety of food-related retailers of all sizes. This will provide the Company with access to a large number of key retail accounts in the United States.
  • In addition, in September 2021 the Company entered into an agreement with FDM Management, LLC (www.fdmsales.com), giving it direct access to FDM Management’s entire sales force, to leverage and activate its existing retail client relationships throughout the United States.
  • During the year, the Company strengthened its sales force with the hiring of a US sales manager, Rob Leichman, who brings over 20 years of direct industry experience and a variety of key retail account relationships and, an Eastern Canada sales manager, Shalom Thompson, who brings over 10 years of Canadian food sales experience and a variety of existing relationships with key retailers in Eastern Canada.

 

About the Company

The Good Shroom Co. operates a portfolio of brands that include traditional cannabis and beverage products. Its aim is to promote the use of functional ingredients such as probiotics and functional mushrooms in consumer products. Its Teonan line consists of beverages that, first and foremost, are high quality and tasty, but also contain a dose of functional mushrooms and probiotics. We all have a daily routine, be it coffee, tea or something else. Why not make that routine functional, for body and mind, by adding probiotics and mushrooms? Up to now, no company has been able to maintain a familiar taste at a fair price while making these drinks truly functional. The Good Shroom Co. has filled that gap and intends to make its brands household names as part of its customers’ daily routine.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Cautionary Note Regarding Forward-Looking Information

This press release contains statements that constitute “forward-looking statements” and “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Corporation with respect to future business activities and sales, including the anticipated orders to be placed for its products. Forward-looking statements are often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions. Investors are cautioned that forward-looking statements are not based on historical facts but instead reflect the Corporation’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Corporation believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed thereon, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements. Among the key factors that could cause actual results to differ materially from those projected are the following: market acceptance of the Company’s hash and other cannabis products, changes in the vendor’s business or strategy, changes in our supplier’s operations and pricing, expectations regarding competition and their pricing strategy; maintaining in good standing all necessary regulatory licenses and authorizations for its products; the benefits, safety, and social acceptance of cannabis related products and no material changes in the legal environment; changes in applicable laws and regulations compliance with extensive government regulation; operational risks related to and COVID-19 or other pandemic and supply chain disruptions and shortages. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. The Company does not intend, and do not assume any obligation, to update the forward-looking statements except as otherwise required by applicable law.

SOURCE The Good Shroom Co Inc.

 

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading